FY2025 · ended Dec 31, 2025 · Revenue $308.05M, +37.2% YoY · Filed Feb 26, 2026
PROCEPT BioRobotics Corporation (PRCT) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $308.1 million and a net loss of $95.6 million. Free cash flow was -$58.3 million. As of Sep 30, 2026 it held $218.4 million in cash and investments and $77.0 million in total debt.
Revenue (TTM)
$352.31M
+17.5% vs year-ago TTM
Net income (TTM)
$-114.86M
-35.8% vs year-ago TTM
Operating cash flow (TTM)
$-76.69M
-7.9% vs year-ago TTM
Free cash flow (TTM)
$-85.07M
-6.7% vs year-ago TTM
EPS (TTM)
$-2.02
-31.6% vs year-ago TTM
Dividend per share
None
Shares outstanding
56.39M
+2.9% vs prior year
Net cash
$141.38M
as of Sep 30, 2026
Operating margin
-33.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- PRCT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Jose, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1588978
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $308.1M | $224.5M | $136.2M | $75.0M | $34.5M |
| Operating income | -$103.9M | -$96.6M | -$109.2M | -$80.7M | -$54.2M |
| Net income | -$95.6M | -$91.4M | -$105.9M | -$87.2M | -$59.9M |
| Diluted EPS | -$1.72 | -$1.75 | -$2.24 | -$1.96 | -$3.63 |
| Operating cash flow | -$49.0M | -$99.2M | -$108.0M | -$80.4M | -$57.3M |
| Free cash flow | -$58.3M | -$103.6M | -$133.2M | -$83.0M | -$57.9M |
| Total assets | $508.1M | $534.0M | $404.7M | $309.3M | $337.0M |
| Total liabilities | $142.2M | $131.8M | $124.0M | $112.3M | $69.9M |
| Stockholders' equity | $365.9M | $402.2M | $280.8M | $197.1M | $267.1M |
| Cash and investments | $286.5M | $333.7M | $257.2M | $221.9M | $304.3M |
| Total debt | $78.5M | $80.2M | $79.2M | $77.3M | $54.1M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 2, 2026 | Oct 2, 2026 |
| 8-K |
Current report
Material agreement
|
Sep 24, 2026 | Sep 23, 2026 |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
All 397 PROCEPT BioRobotics Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.